Literature DB >> 34494873

Natural-Product-Based Solutions for Tropical Infectious Diseases.

Oyelola Adegboye1,2,3, Matt A Field3,4,5,6, Andreas Kupz3,5, Saparna Pai3,5, Dileep Sharma3,7, Michael J Smout3,5, Phurpa Wangchuk3,5, Yide Wong3,4,5, Claire Loiseau3,5.   

Abstract

About half of the world's population and 80% of the world's biodiversity can be found in the tropics. Many diseases are specific to the tropics, with at least 41 diseases caused by endemic bacteria, viruses, parasites, and fungi. Such diseases are of increasing concern, as the geographic range of tropical diseases is expanding due to climate change, urbanization, change in agricultural practices, deforestation, and loss of biodiversity. While traditional medicines have been used for centuries in the treatment of tropical diseases, the active natural compounds within these medicines remain largely unknown. In this review, we describe infectious diseases specific to the tropics, including their causative pathogens, modes of transmission, recent major outbreaks, and geographic locations. We further review current treatments for these tropical diseases, carefully consider the biodiscovery potential of the tropical biome, and discuss a range of technologies being used for drug development from natural resources. We provide a list of natural products with antimicrobial activity, detailing the source organisms and their effectiveness as treatment. We discuss how technological advancements, such as next-generation sequencing, are driving high-throughput natural product screening pipelines to identify compounds with therapeutic properties. This review demonstrates the impact natural products from the vast tropical biome have in the treatment of tropical infectious diseases and how high-throughput technical capacity will accelerate this discovery process.

Entities:  

Keywords:  drug development; infectious disease; microbiology; natural products; tropics

Mesh:

Substances:

Year:  2021        PMID: 34494873      PMCID: PMC8673330          DOI: 10.1128/CMR.00348-20

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   50.129


  325 in total

1.  Strategies for the discovery of new natural products by genome mining.

Authors:  Malek Zerikly; Gregory L Challis
Journal:  Chembiochem       Date:  2009-03-02       Impact factor: 3.164

2.  Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group.

Authors:  Lorenzo Zammarchi; Maurizio Bonati; Marianne Strohmeyer; Marco Albonico; Ana Requena-Méndez; Zeno Bisoffi; Alessandra Nicoletti; Hector H García; Alessandro Bartoloni
Journal:  Trop Med Int Health       Date:  2017-06-01       Impact factor: 2.622

3.  Anti-inflammatory activity of Vismia guianensis (Aubl.) Pers. extracts and antifungal activity against Sporothrix schenckii.

Authors:  A H Oliveira; G G de Oliveira; F Carnevale Neto; D F Portuondo; A Batista-Duharte; I Z Carlos
Journal:  J Ethnopharmacol       Date:  2016-11-14       Impact factor: 4.360

Review 4.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

5.  SMURF: Genomic mapping of fungal secondary metabolite clusters.

Authors:  Nora Khaldi; Fayaz T Seifuddin; Geoff Turner; Daniel Haft; William C Nierman; Kenneth H Wolfe; Natalie D Fedorova
Journal:  Fungal Genet Biol       Date:  2010-06-08       Impact factor: 3.495

6.  Antifilarial activity of Caesalpinia bonducella against experimental filarial infections.

Authors:  R L Gaur; M K Sahoo; S Dixit; N Fatma; S Rastogi; D K Kulshreshtha; R K Chatterjee; P K Murthy
Journal:  Indian J Med Res       Date:  2008-07       Impact factor: 2.375

Review 7.  Tetracycline therapy: update.

Authors:  Marilyn C Roberts
Journal:  Clin Infect Dis       Date:  2003-01-28       Impact factor: 9.079

8.  Identification of inhibitors of Plasmodium falciparum gametocyte development.

Authors:  Sandra Duffy; Vicky M Avery
Journal:  Malar J       Date:  2013-11-11       Impact factor: 2.979

9.  Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis.

Authors:  Leandro B R Silva; Lucas S Dias; Glauce M G Rittner; Julián E Muñoz; Ana C O Souza; Joshua D Nosanchuk; Luiz R Travassos; Carlos P Taborda
Journal:  Front Microbiol       Date:  2017-06-14       Impact factor: 5.640

Review 10.  Clinical Development of New TB Vaccines: Recent Advances and Next Steps.

Authors:  Mark Hatherill; Richard G White; Thomas R Hawn
Journal:  Front Microbiol       Date:  2020-01-30       Impact factor: 5.640

View more
  3 in total

1.  Discovery of Drug Candidates for Specific Human Disease Based on Natural Products of Gut Microbes.

Authors:  Cheng-Yu Wang; Qing-Feng Wen; Qiao-Qiao Wang; Xia Kuang; Chuan Dong; Zi-Xin Deng; Feng-Biao Guo
Journal:  Front Microbiol       Date:  2022-06-15       Impact factor: 6.064

Review 2.  Indigenous Uses, Phytochemical Analysis, and Anti-Inflammatory Properties of Australian Tropical Medicinal Plants.

Authors:  Karma Yeshi; Gerry Turpin; Tenzin Jamtsho; Phurpa Wangchuk
Journal:  Molecules       Date:  2022-06-15       Impact factor: 4.927

3.  Sesquiterpene Lactones with Dual Inhibitory Activity against the Trypanosoma brucei Pteridine Reductase 1 and Dihydrofolate Reductase.

Authors:  Katharina Possart; Fabian C Herrmann; Joachim Jose; Maria P Costi; Thomas J Schmidt
Journal:  Molecules       Date:  2021-12-27       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.